Citations

Mayo Clinic

Showing 10 of 108599 citations.

Distal Junctional Failure Following Pediatric Spinal Fusion
Floccari, Lorena V. , Su, Alvin W.Y. , McIntosh, Amy L. , Rathjen, Karl E. , Shaughnessy, William J. , Su, Alvin W, Larson, A. Noelle

Journal of Pediatric Orthopaedics | May 26, 2017 | Volume: 39 | Issue: 4 | Pages: 202-208

10.1097/bpo.0000000000000898 | PMID 30839481 Get It

Background: Adjacent segment pathology is a known complication after spinal fusion, but little has been reported on junctional failure. A series of adolescent patients presented with acute distal junctional failure (DJF). We sought to determine any common features of these patients to develop a prevention strategy. Methods: A retrospective review was conducted of pediatric patients who developed DJF after instrumented spinal fusion performed at 2 institutions from 1999 to 2013. Patients with proximal junctional failure or junctional kyphosis without failure were excluded. Results: Fifteen subjects were identified with mean follow-up of 38 months. Distal failure occurred a mean of 60 days after index surgery, with history of minor trauma in 4 patients. Failures included 3-column Chance fracture (11) or instrumentation failure (4). Thirteen patients presented with back pain and/or acute kyphosis, whereas 2 asymptomatic patients presented with healed fractures. Two patients also developed new onset of severe lower extremity neurological deficit after fracture, which improved but never resolved after revision. A total of 13/15 subjects required revision surgery, typically within 1 week. Complications associated with revision surgery were encountered in 8 patients (62%). Major complications that required return to the operating room included 2 deep infections, 2 instrumentation failures, and dense lower extremity paralysis that improved after medial screw revision and decompression. At final follow-up, 10 patients are asymptomatic, 2 have persistent neurological deficit, 2 have chronic pain, and 1 has altered gait with gait aid requirement. Conclusions: This study analyzes a heterogenous cohort of spinal fusion patients who developed DJF from 3-column Chance fracture or instrumentation failure. Revision surgery is typically required, but has a high complication rate and can result in severe neurological deficit, highlighting the morbidity of this complication. It is unclear whether level of the lowest instrumented vertebra contributes to DJF. Increased awareness of junctional failure in children may prompt additional studies to further characterize risk factors and preventative strategies. Level of Evidence: Level IV—study-type case series.
Faculty Opinions recommendation of Sequence-Directed Covalent Protein-DNA Linkages in a Single Step Using HUH-Tags.
Maher, Jim

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | May 26, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.727593188.793532443 Get It

Predictive models in the diagnosis and treatment of autoimmune epilepsy
Dubey, Divyanshu , Singh, Jaysingh , Pittock, Sean J. , Flanagan, Eoin P. , Lennon, Vanda A. , Tillema, Jan‐Mendelt , Shin, Cheolsu, So, Elson, Cascino, Gregory D. , Wingerchuk, Dean M. , Hoerth, Matthew T., Shih, Jerry J. , Nickels, Katherine , McKeon, Andrew , Pittock, S J , Britton, Jeffrey W. , Wirrell, Elaine , So, Elson L., Flanagan, E P , McKeon, Andrew , Dubey, Divyanshu , Nickels, Katherine C

Epilepsia | May 26, 2017 | Volume: 58 | Issue: 7 | Pages: 1181-1189

10.1111/epi.13797 | PMID 28555833 Get It

Summary Objective To validate predictive models for neural antibody positivity and immunotherapy response in epilepsy. Methods We conducted a retrospective study of epilepsy cases at Mayo Clinic (Rochester‐ MN ; Scottsdale‐ AZ , and Jacksonville‐ FL ) in whom autoimmune encephalopathy/epilepsy/dementia autoantibody testing profiles were requested (06/30/2014‐06/30/2016). An Antibody Prevalence in Epilepsy ( APE ) score, based on clinical characteristics, was assigned to each patient. Among patients who received immunotherapy, a Response to Immunotherapy in Epilepsy ( RITE ) score was assigned. Favorable seizure outcome was defined as >50% reduction of seizure frequency at the first follow‐up . Results Serum and cerebrospinal fluid (CSF) from 1,736 patients were sent to the Mayo Clinic Neuroimmunology Laboratory for neural autoantibody evaluation. Three hundred eighty‐seven of these patients met the diagnostic criteria for epilepsy. Central nervous system (CNS)–specific antibodies were detected in 44 patients. Certain clinical features such as new‐onset epilepsy, autonomic dysfunction, viral prodrome, faciobrachial dystonic seizures/oral dyskinesia, inflammatory CSF profile, and mesial temporal magnetic resonance imaging (MRI) abnormalities had a significant association with positive antibody results. A significantly higher proportion of antibody‐positive patients had an APE score ≥4 (97.7% vs. 21.6%, p < 0.01). Sensitivity and specificity of an APE score ≥4 to predict presence of specific neural auto‐antibody were 97.7% and 77.9%, respectively. In the subset of patients who received immunotherapy (77), autonomic dysfunction, faciobrachial dystonic seizures/oral dyskinesia, early initiation of immunotherapy, and presence of antibodies targeting plasma membrane proteins (cell‐surface antigens) were associated with favorable seizure outcome. Sensitivity and specificity of a RITE score ≥7 to predict favorable seizure outcome were 87.5% and 83.8%, respectively. Significance APE and RITE scores can aid diagnosis, treatment, and prognostication of autoimmune epilepsy. A PowerPoint slide summarizing this article is available for download in the Supporting Information section here .
AAPM Medical Physics Practice Guideline 8.a.: Linear accelerator performance tests
Smith, Koren, Balter, Peter , Duhon, John, White, Gerald A., Vassy, David L., Miller, Robin A., Serago, Christopher F., Fairobent, Lynne

Journal of Applied Clinical Medical Physics | May 26, 2017 | Volume: 18 | Issue: 4 | Pages: 23-39

10.1002/acm2.12080 | PMID 28548315 Get It

AbstractPurposeThe purpose of this guideline is to provide a list of critical performance tests in order to assist the Qualified Medical Physicist (QMP) in establishing and maintaining a safe and effective quality assurance (QA) program. The performance tests on a linear accelerator (linac) should be selected to fit the clinical patterns of use of the accelerator and care should be given to perform tests which are relevant to detecting errors related to the specific use of the accelerator.MethodsA risk assessment was performed on tests from current task group reports on linac QA to highlight those tests that are most effective at maintaining safety and quality for the patient. Recommendations are made on the acquisition of reference or baseline data, the establishment of machine isocenter on a routine basis, basing performance tests on clinical use of the linac, working with vendors to establish QA tests and performing tests after maintenance.ResultsThe recommended tests proposed in this guideline were chosen based on the results from the risk analysis and the consensus of the guideline's committee. The tests are grouped together by class of test (e.g., dosimetry, mechanical, etc.) and clinical parameter tested. Implementation notes are included for each test so that the QMP can understand the overall goal of each test.ConclusionThis guideline will assist the QMP in developing a comprehensive QA program for linacs in the external beam radiation therapy setting. The committee sought to prioritize tests by their implication on quality and patient safety. The QMP is ultimately responsible for implementing appropriate tests. In the spirit of the report from American Association of Physicists in Medicine Task Group 100, individual institutions are encouraged to analyze the risks involved in their own clinical practice and determine which performance tests are relevant in their own radiotherapy clinics.
A novel community driven software for functional enrichment analysis of extracellular vesicles data
Pathan, Mohashin , Keerthikumar, Shivakumar , Chisanga, David , Ang, Ching‐Seng , Askenase, Philip W., Batagov, Arsen O., Benito‐Martín, Alberto , Clayton, Aled , Collino, Federica , Vizio, Dolores Di , Falcón‐Pérez, Juan Manuel , Fonseca, Pedro , Fonseka, Pamali , Fontana, Simona , Gho, Yong Song , Hendrix, An , Hoen, Esther N. M. Nolte-â€TMt, Iraci, Nunzio , Kastaniegaard, Kenneth , Kislinger, Thomas , Kowal, Joanna , Kurochkin, Igor V. , Leonardi, Tommaso , Liang, Yaxuan , Llorente, Alicia , Lunavat, Taral R. , Maji, Sayantan , Øverbye, Anders , Peinado, Héctor , Principe, Simona, Ronquist, G. , Royo, Félix , Sahoo, Susmita , Spinelli, Cristiana , Stensballe, Allan , Théry, Clotilde , Herwijnen, Martijn J. C. van , Wauben, Marca H. M. , Welton, Joanne L. , Zhao, Kening , Mathivanan, Suresh , Fonseca, Pedro , Fonseka, Pamali , Fontana, Simona , Iraci, Nunzio , Kastaniegaard, Kenneth , Kowal, Joanna , Leonardi, Tommaso , Øverbye, Anders , Peinado, Héctor , Spinelli, Cristiana , Welton, Joanne L , Alessandro, Riccardo , Camussi, Giovanni , Hoen, Esther N. M. Nolte‐‘t , Villafiorita‐Monteleone, Francesca , Panaretakis, Theocharis , Patel, Tushar , Pluchino, Stefano , Falcón-Perez, Juan Manual

Journal of Extracellular Vesicles | May 26, 2017 | Volume: 6 | Issue: 1 | Pages: No page available

10.1080/20013078.2017.1321455 | PMID 28717418 Get It

ABSTRACTBioinformatics tools are imperative for the in depth analysis of heterogeneous high‐throughput data. Most of the software tools are developed by specific laboratories or groups or companies wherein they are designed to perform the required analysis for the group. However, such software tools may fail to capture “what the community needs in a tool”. Here, we describe a novel community‐driven approach to build a comprehensive functional enrichment analysis tool. Using the existing FunRich tool as a template, we invited researchers to request additional features and/or changes. Remarkably, with the enthusiastic participation of the community, we were able to implement 90% of the requested features. FunRich enables plugin for extracellular vesicles wherein users can download and analyse data from Vesiclepedia database. By involving researchers early through community needs software development, we believe that comprehensive analysis tools can be developed in various scientific disciplines.
Renal functional outcomes in patients undergoing percutaneous cryoablation or partial nephrectomy for a solitary renal mass
Mason, Ross , Atwell, Thomas D. , Lohse, Christine M. , Bhindi, Bimal , Weisbrod, Adam J. , Boorjian, Stephen A. , Leibovich, Bradley C. , Schmit, Grant D. , Thompson, R. Houston, Mason, Ross J , Lohse, Christine, Weisbrod, Adam

BJU International | May 26, 2017 | Volume: 120 | Issue: 4 | Pages: 544-549

10.1111/bju.13917 | PMID 28548236 Get It

Objectives To compare renal functional changes after percutaneous cryoablation ( PCA ) or partial nephrectomy ( PN ). Patients and Methods Patients who underwent PCA or PN for a solitary renal mass at a single institution were identified (2003–2013). Estimated glomerular filtration rates ( eGFR s) were calculated at baseline, discharge, and at the 3‐month follow‐up using the Chronic Kidney Disease Epidemiology Collaboration equation. Changes in renal function were compared between groups using 1:1 propensity score ( PS ) matching, adjustment for PS quintile, and inverse probability weighting ( IPW ). Results There were 2 040 procedures available for the PS analyses, including 448 PCA and 1 592 PN . After PS adjustments, there were no significant differences in baseline clinical features between PCA and PN patients. In the PS ‐matched analysis, the change in eGFR from baseline to discharge for PCA and PN patients was −3.1 and −1.1 mL /min/1.73 m 2 , respectively ( P = 0.038), with percentage changes of −4.5% and 0% respectively ( P = 0.006). From baseline to the 3‐month follow‐up, the absolute change in eGFR for PCA and PN patients was −4.3 and −2.1 mL /min/1.73 m 2 , respectively ( P = 0.008), and the percentage change was −6.1% and −2.4% respectively ( P = 0.005). Similar results were obtained after adjusting for PS quintiles and in the IPW analysis. Importantly, the rate of chronic kidney disease stage progression at the 3‐month follow‐up was similar between the groups (21% vs 18%). Conclusions Our results confirm that both PCA and PN have a minor impact on renal function. While we observed a statistically greater decline in eGFR after PCA compared with PN , both approaches result in excellent preservation of renal function.
The value transformation of health care: Impact on neuromuscular and electrodiagnostic medicine
Suk, Millie, Jones, Lyell K. , Narayanaswami, Pushpa , Jones, Lyell K

Muscle & Nerve | May 25, 2017 | Volume: 56 | Issue: 4 | Pages: 679-683

10.1002/mus.25699 | PMID 28545159 Get It

ABSTRACTBeginning in 2017, most physicians who participate in Medicare are subject to the Medicare Access and CHIP Reauthorization Act (MACRA), the milestone legislation that signals the US health care system's transition from volume‐based to value‐based care. Here we review emerging trends in development of value‐based healthcare systems in the US. MACRA and the resulting Quality Payment Program create 2 participation pathways, the Merit‐based Incentive Payment System (MIPS) and the Advanced Alternative Payment Model (AAPM) pathway. Although there are several program incentives for AAPM participation, to date there have been few AAPM options for specialists. MIPS and its widening bonus and penalty window will likely be the primary participation pathway in the early years of the program. Value‐based payment has the potential to reshape health care delivery in the United States, with implications for neuromuscular and electrodiagnostic (EDX) specialists. Meaningful quality measures are required for neuromuscular and EDX specialists. Muscle Nerve 56: 679–683, 2017
Keyboard: A Novel Bayesian Toxicity Probability Interval Design for Phase I Clinical Trials
Yan, Fangrong , Mandrekar, Sumithra J. , Yuan, Ying

Clinical Cancer Research | May 25, 2017 | Volume: 23 | Issue: 15 | Pages: 3994-4003

10.1158/1078-0432.ccr-17-0220 | PMID 28546227 Get It

Abstract The primary objective of phase I oncology trials is to find the MTD. The 3+3 design is easy to implement but performs poorly in finding the MTD. A newer design, such as the modified toxicity probability interval (mTPI) design, provides better accuracy to identify the MTD but tends to overdose patients. We propose the keyboard design, an intuitive Bayesian design that conducts dose escalation and de-escalation based on whether the strongest key, defined as the dosing interval that most likely contains the current dose, is below or above the target dosing interval. The keyboard design can be implemented in a simple way, similar to the traditional 3+3 design, but provides more flexibility for choosing the target toxicity rate and cohort size. Our simulation studies demonstrate that compared with the 3+3 design, the keyboard design has favorable operating characteristics in terms of identifying the MTD. Compared with the mTPI design, the keyboard design is safer, with a substantially lower risk of treating patients at overly toxic doses, and has the better precision to identify the MTD, thereby providing a useful upgrade to the mTPI design. Software freely available at http://www.trialdesign.org facilitates the application of the keyboard design. Clin Cancer Res; 23(15); 3994–4003. ©2017 AACR. See related commentary by Paoletti et al., p. 3977
Automated low‐contrast pattern recognition algorithm for magnetic resonance image quality assessment
Ehman, Morgan O., Bao, Zhonghao , Stiving, Scott O., Kasam, Mallikarjunarao , Lanners, Dianna , Peterson, Teresa, Jonsgaard, Renee , Carter, Rickey E. , McGee, Kiaran P. , Kasam, Mallik, Carter, Rickey, Carter, Rickey E

Medical Physics | May 25, 2017 | Volume: 44 | Issue: 8 | Pages: 4009-4024

10.1002/mp.12370 | PMID 28543961 Get It

PurposeLow contrast (LC) detectability is a common test criterion for diagnostic radiologic quality control (QC) programs. Automation of this test is desirable in order to reduce human variability and to speed up analysis. However, automation is challenging due to the complexity of the human visual perception system and the ability to create algorithms that mimic this response. This paper describes the development and testing of an automated LC detection algorithm for use in the analysis of magnetic resonance (MR) images of the American College of Radiology (ACR) QC phantom.MethodsThe detection algorithm includes fuzzy logic decision processes and various edge detection methods to quantify LC detectability. Algorithm performance was first evaluated using a single LC phantom MR image with the addition of incremental zero mean Gaussian noise resulting in a total of 200 images. A c‐statistic was calculated to determine the role of CNR to indicate when the algorithm would detect ten spokes. To evaluate inter‐rater agreement between experienced observers and the algorithm, a blinded observer study was performed on 196 LC phantom images acquired from nine clinical MR scanners. The nine scanners included two MR manufacturers and two field strengths (1.5 T, 3.0 T). Inter‐rater and algorithm‐rater agreement was quantified using Krippendorff's alpha.ResultsFor the Gaussian noise added data, CNR ranged from 0.519 to 11.7 with CNR being considered an excellent discriminator of algorithm performance (c‐statistic = 0.9777). Reviewer scoring of the clinical phantom data resulted in an inter‐rater agreement of 0.673 with the agreement between observers and algorithm equal to 0.652, both of which indicate significant agreement.ConclusionsThis study demonstrates that the detection of LC test patterns for MR imaging QC programs can be successfully developed and that their response can model the human visual detection system of expert MR QC readers.
Sex differences in fitness and cardiac function during exercise in adolescents with chronic fatigue
Pianosi, Paolo T. , Emerling, Eric, Mara, Kristin C. , Weaver, Amy L. , Pianosi, P T , Fischer, Philip R. , Mara, Kristin C

Scandinavian Journal of Medicine & Science in Sports | May 25, 2017 | Volume: 28 | Issue: 2 | Pages: 524-531

10.1111/sms.12922 | PMID 28543923 Get It

Females demonstrate less robust Frank‐Starling mechanism with respect to cardiac preload than males at rest. We asked whether this phenomenon would also affect cardiac performance during exercise. We hypothesized that stroke volume (SV) response to exercise would be more limited in deconditioned females such that cardiac output would be mainly rate dependent, compared with males. We conducted a chart audit of clinical exercise tests performed by adolescents with chronic fatigue. Oxygen uptake () was measured breath‐by‐breath at rest and during cycle ergometry, while cardiac output was measured by acetylene rebreathing at rest plus 2‐3 subthreshold workloads. SV response was analyzed in two ways: after normalization for body surface area (SV index, SVI) and as percentage change from resting values. Among 304 adolescents (78% females) with chronic fatigue, 189 (80%) of 236 females and 52 (76%) of 68 males were deconditioned (peakO2 <90% predicted). Heart rate trajectory during exercise was steeper for unfit than fit females, 70 vs 61 beat·min−1 per L·min−1 , (P=.003); but not for males, 47 vs 42 beat·min−1 per L·min−1 (P=.23). The highest measured SVI did not differ between unfit vs fit females (42.8 vs 41.5 mL·m−2, P=.39) while fit males showed larger SV during exercise than their unfit peers (highest SVI 55.9 vs 48.0 mL·m−2, P=.014). Both qualitative and quantitative sex differences exist in SV responses to exercise among chronically fatigued adolescents, suggesting volume loading may be more efficacious in girls.